Correction to "Protecting infants against RSV disease: an impact and cost-effectiveness comparison of long-acting monoclonal antibodies and maternal vaccination" [The Lancet Regional Health - Europe 38 (2024) 100829]

Lancet Reg Health Eur. 2024 Sep 11:45:101073. doi: 10.1016/j.lanepe.2024.101073. eCollection 2024 Oct.

David Hodgson¹, Neil Wilkins², Edwin van Leeuwen^{1

2}, Conall H Watson², Jonathan Crofts², Stefan Flasche¹, Mark Jit¹, Katherine E Atkins^{1

3}

¹ Centre of Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.
² UK Health Security Agency, London, UK.
³ Centre for Global Health, Usher Institute, Edinburgh Medical School, University of Edinburgh, UK.

Abstract

[This corrects the article DOI: 10.1016/j.lanepe.2023.100829.].